Agea Medical has its sights on an $8 million offering

May 23, 2013 by Sony Salzman

Agea Medical is $2 million shy of its $8 million funding round goal

Officials at Agea Medical said it is closing in on an $8 million funding round.

The Redwood City, Calif.-based medical device company has raised $6 million for its coffers and is close to its goal.

Agea markets a system that uses vapor to ablate uterine cavity tissues. The company develops medical technology to treat excessive menstrual bleeding, a condition the company says impacts 1 in 4 women in the U.S.

Sign up to get our free newsletters delivered right to your inbox.

In 2011, the company landed a $13.3 million private equity funding round led by medical device giant Covidien.

Company SEC filings did not disclose the investors involved in the current offering.